65,437 trials
Rheumatoid Arthritis
Primary: Disease Activity Score (DAS28) — 2.93; 2.73; 2.72; 3.17 units on a scale — p=0.144
Poor Quality Sleep · Opiate Addiction
Primary: Sleep Quality, as Measured by Total Sleep Time — 339; 329 minutes — p=.05
Hodgkin Disease · Non-Hodgkin Lymphoma · Multiple Myeloma
Primary: Incidence of Clinically Significant Bacteremia — 3; 9 participants
Contraception · Female Contraception
Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day Rule…
Metastatic Pancreatic Cancer
Primary: Overall Survival (OS) — 8.5; 6.7 months — p=<0.0001
Schizophrenia · Schizoaffective Disorder · Other Primary Psychotic Disorders
Primary: UCSD Performance-based Skills Assessment Total Score (Measures Functional Capacity) — 82.7; 84.4 units on a scale
Diabetes Mellitus, Type 2
Primary: Change From Baseline (Day -1) to Day 28 in Twenty-Four-Hour Weighted Average Glucose (24-Hour WAG) — -18.88; -11.95; -4.72; 8.52 mg/dL — p=0.006
Asthma
Primary: Incidence of Adverse Events — 9; 9; 9; 9 Participants
Binge Eating Disorder
Primary: Frequency of Binge Eating in the Past 28 Days — 16.06; 14.48; 6.26; 7.40 days
Aortic Dissection
Primary: Disease-, Procedure- or Device-related Mortality at 12 Months Post-procedure — 9; 1; 1 participants
Sickle Cell Disease
Primary: Pharmacokinetics: Area Under the Concentration-Time Curve (AUC) of Prasugrel Active Metabolite (Pras-AM) — 8.68; 14.5; 20.8; 31.3 nanograms*hour per milliliter (ng*hr/mL)
Hormone-resistant Prostate Cancer · Recurrent Prostate Cancer
Primary: Best Overall Response — 0; 14; 21; 8 Participants
Corneal Ulcer · Eye Infections, Fungal
Primary: Best Spectacle-corrected logMAR Visual Acuity — 0.39; 0.57 logMAR — p=0.006
Myopia
Primary: Slit Lamp Findings — 0; 0 eyes
Acne Rosacea
Primary: Erythema Severity — 44.53 Erythema percent improvement